THERAPIES FOR TREATING PROCTITIS WITH POLYCLONAL ANTI-TNFALPHA ANTIBODIES
The present invention is directed to an antibody composition for use in treating proctitis, wherein the antibody composition comprises intact blood-derived polyclonal antibodies that bind to a human tumour necrosis factor α (TNFα). The invention also relates to associated uses, methods, solid compos...
Gespeichert in:
Hauptverfasser: | , |
---|---|
Format: | Patent |
Sprache: | eng ; fre ; ger |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The present invention is directed to an antibody composition for use in treating proctitis, wherein the antibody composition comprises intact blood-derived polyclonal antibodies that bind to a human tumour necrosis factor α (TNFα). The invention also relates to associated uses, methods, solid compositions, and liquid compositions using/comprising the same. |
---|